ResearcherConjupro Biotherapeutics, Inc.No recent work listed

Jiangfeng Su

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2022: 1 trial

Trials 1

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers Study director NCT05043987 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.